Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 1, 2005, Pages 170-187

  Avila, Gina E ^a   Zheng, Xi ^a   Xiao, Xing Cui ^a   Ryan, Amanda D ^a   Hansson, Annette ^a   Suh, Junghan ^c,f   Rabson, Arnold B ^b,c   Chang, Richard L ^a   Weichung, Joe Shih ^b,d   Lin, Yong ^d   Crowell, Pamela ^e   Yao, Ping Lu ^a   You, Rong Lou ^a   Conney, Allan H ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e INDIANA UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISINDOLYLMALEIMIDE; CASPASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR; PROTEIN P21; RETINOIC ACID; ROTTLERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; MALE; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN CONTENT; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BODY WEIGHT; CELL CYCLE; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEOPLASM TRANSPLANTATION; PACLITAXEL; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE C; RETINOBLASTOMA PROTEIN; SULINDAC; TETRADECANOYLPHORBOL ACETATE; TRANSPLANTATION, HETEROLOGOUS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 25644458432     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.087585     Document Type: Article

References (40)

1. Arita Y, O'Driscoll KR, and Weinstein IB (1994) Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate. Int J Cancer 56:229-235.
2. Blutt SE, Allegretto EA, Pike JW, and Weigel NL (1997) 1,25-Dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138:1491-1497.
3. Chen GQ, Shen ZX, Wu F, Han JY, Miao JM, Zhong HJ, Li XS, Zhao JQ, Zhu J, Fang ZW, et al. (1996) Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia 10:825-828.
4. Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, and Luo K (2004) Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol 6:366-372.
5. Connell-Crowley L, Harper JW, and Goodrich DW (1997) Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 8:287-301.
6. Cui XX, Chang RL, Zheng X, Woodward D, Strair R, and Conney AH (2002) A sensitive bioassay for measuring blood levels of 12-O-tetradecanoylphorbol-13- acetate (TPA) in patients: preliminary pharmacokinetic studies. Oncol Res 13:169-174.
7. cip-mediated G(1) arrest. J Cell Sci 113:3025-3035.
8. Ergun S, Carlsoo B, and Zheng X (1999) Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol Allied Sci 24:280-285.
9. Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, Kuroki T, Li L, Yuspa SH, and Kazanietz MG (2000) Involvement of protein kinase Cä (PKCä) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCä. J Biol Chem 275:7574-7582.
10. Garzotto M, Haimovitz-Friedman A, Liao WC, White-Jones M, Huryk R, Heston WD, Cardon-Cardo C, Kolesnick R, and Fuks Z (1999) Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. Cancer Res 59:5194-5201.
11. Garzotto M, White-Jones M, Jiang Y, Ehleiter D, Liao WC, Haimovitz-Friedman A, Fuks Z, and Kolesnick R (1998) 12-O-Tetradecanoylphorbol- 13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res 58:2260-2264.
12. Greenlee RT, Murray T, Bolden S, and Wingo PA (2000) Cancer statistics, 2000. CA Cancer J Clin 50:7-33.
13. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, and Johannes FJ (1996) Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392:77-80.
14. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, and Marks F (1994) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199:93-98.
15. Guilbaud NF, Gas N, Dupont MA, and Valette A (1990) Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. J Cell Physiol 145:162-172.
16. Han ZT, Zhu XX, Yang RY, Sun JZ, Tian GF, Liu XJ, Cao GS, Newmark HL, Conney AH, and Chang RL (1998) Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity. Proc Natl Acad Sci USA 95:5357-5361.
17. Hsu JC (1996) Multiple Comparisons: Theory and Methods. Chapman & Hall, New York.
18. Huberman E and Callaham MF (1979) Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci USA 76:1293-1297.
19. Ishino K, Fukazawa H, Shikano M, Ohba M, Kuroki T, and Uehara Y (2002) Enhancement of anchorage-independent growth of human pancreatic carcinoma MIA PaCa-2 cells by signaling from protein kinase C to mitogen-activated protein kinase. Mol Carcinog 34:180-186.
20. Koeffler HP, Bar-Eli M, and Territo M (1980) Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia. J Clin Investig 66:1101-1108.
21. Konno S, Hsieh TC, Wu JM, Chen Y, Chiao JW, and Mallouh C (1996) Growth control of human prostatic cancer cells by the phorbol ester TPA: possible involvement of protein kinases. Anticancer Res 16:1843-1849.
22. Li L, Aggarwal BB, Shishodia S, Abbruzzese J, and Kurzrock R (2004) Nuclear factor-κB and IκB kinase are constitutively active in human pancreatic cells and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101:2351-2362.
23. Lindsey JK (1993) Models for Repeated Measurements. Claredon Press, Oxford.
24. Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, and Schmid RM (2003) Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer. Int J Cancer 105:735-746.
25. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, and Schachtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197.
26. Pasquali D, Rossi V, Prezioso D, Gentile V, Colantuoni V, Lotti T, Bellastella A, and Sinisi AA (1999) Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells. J Clin Endocrinol Metab 84:1463-1469.
27. Pegoraro L, Abrahm J, Cooper RA, Levis A, Lange B, Meo P, and Rovera G (1980) Differentiation of human leukemias in response to 12-O- tetradecanoylphorbol-13-acetate in vitro. Blood 55:859-862.
28. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, and Fair WR (1996) Persistent membrane translocation of protein kinase C alpha during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 7:419-428.
29. Remy I, Montmarquette A, and Michnick SW (2004) PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 6:358-365.
30. Rickard KL, Gibson PR, Young GP, and Phillips WA (1999) Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro. Carcinogenesis 20:977-984.
31. Rovera G, O'Brien TG, and Diamond L (1979) Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science (Wash DC) 204:868-870.
32. Salge U, Kilian P, Neumann K, Elsasser HP, Havemann K, and Heidtmann HH (1990) Differentiation capacity of human non-small-cell lung cancer cell lines after exposure to phorbol ester. Int J Cancer 45:1143-1150.
33. Schavinsky-Khrapunsky Y, Huleihel M, Aboud M, and Torgeman A (2003) TPA activates p21WAF-1 promoter in human T-cells through its second most upstream Sp1 site. Biochem Biophys Res Commun 304:696-700.
34. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, et al. (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80:1830-1837.
35. Strair RK, Schaar D, Goodell L, Aisner J, Chin KV, Eid J, Senzon R, Cui XX, Han ZT, Knox B, et al. (2002) Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate. Clin Cancer Res 8:2512-2518.
36. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
37. Yamamoto Y, Yin MJ, Lin KM, and Gaynor RB (1999) Sulindac inhibits activation of the NF-κB pathway. J Biol Chem 274:27307-27314.
38. Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, et al. (2004) Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64:4394-4399.
39. Zheng X, Chang RL, Cui XX, Avila GE, Lee S, Lu YP, Lou YR, Shih WJ, Lin Y, Reuhl K, et al. (2004) Inhibitory effect of 12-O-tetradecanoylphorbol-13- acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice. Cancer Res 64:1811-1820.
40. 3 and sodium butyrate on differentiation in HL-60 cells. Oncol Res 12:419-427.